Sick of high drug prices, insurers join hospitals to make their own generic medications

23 January 2020 - Everyone complains about high drug prices. But hospitals — and now insurers — are trying to ...

Read more →

Cimzia (certolizumab pegol) now approved in Canada for the treatment of non-radiographic axial spondyloarthritis

15 January 2020 - UCB Canada announced today that Health Canada has approved Cimzia (certolizumab pegol) for the treatment of adults ...

Read more →

Janssen seeks expanded use of Spravato (esketamine) nasal spray in Europe as a treatment for depressive symptoms in adults with major depressive disorder who have current suicidal ideation with intent

15 January 2020 - In two pivotal Phase 3 trials, Spravato combined with comprehensive standard of care achieved statistically significant ...

Read more →

Differences in health technology assessment recommendations among European jurisdictions: the role of practice variations

14 January 2020 - HTA recommendations vary widely throughout Europe, even for the same medicine. ...

Read more →

Thousands to benefit as PHARMAC set to fund better diabetes drugs

15 January 2020 - Better diabetes drugs are set to be publicly funded - a breakthrough that will help keep ...

Read more →

Clovis Oncology’s Rubraca (rucaparib) granted FDA priority review for advanced prostate cancer

15 January 2020 - FDA has assigned PDUFA date of 15 May 2020. ...

Read more →

NICE recommends Ibrance and Lynparza, rejects Keytruda and Xospata

15 January 2020 - Cost-effectiveness watchdog issues a round of draft and final guidance. ...

Read more →

U.S. FDA accepts for priority review Bristol-Myers Squibb’s application for Opdivo (nivolumab) plus Yervoy (ipilimumab) in first-line non-small cell lung cancer

15 January 2020 - Application based on results from Part 1 of Phase 3 CheckMate-227 study. ...

Read more →

Reform at the FDA—in need of reform

14 January 2020 - On 23 December 2016, the US FDA announced the approval of nusinersen, the first drug for the ...

Read more →

Democrats zero in on high drug prices in Iowa debate

14 January 2020 - Until Tuesday, nearly every single Democratic primary debate has focused on the same health care issue: ...

Read more →

NICE rejects Keytruda, asks for more information

15 January 2020 - NICE has published a new draft guidance not recommending MSD’s cancer blockbuster Keytruda (pembrolizumab) for untreated ...

Read more →

FDA approval and regulation of pharmaceuticals, 1983-2018

14 January 2020 - How has the regulation of prescription drugs evolved from the 1980s to 2018, and what trends have ...

Read more →

PHARMAC considering new medicines for type 2 diabetes mellitus

15 January 2020 - PHARMAC is seeking proposals from pharmaceutical suppliers for new medicines that could help New Zealanders living ...

Read more →

TLV has decided to reconsider the subsidy for Xeljanz

14 January 2020 - When TLV decided that Xeljanz should be included in the high-cost protection, this was justified by the ...

Read more →

Proposal to fund betamethasone dipropionate with calcipotriol (Enstilar) foam spray for psoriasis

15 January 2020 - PHARMAC is seeking feedback on a proposal to fund a new topical psoriasis medicine, betamethasone dipropionate ...

Read more →

Amazon Australia signals pharmacy foray with new trademark application

14 January 2020 - The local arm of retail giant Amazon has filed a trademark for the term "Amazon Pharmacy", ...

Read more →